With a significant increase in rabies exposures this year, Rodney Rohde, PhD, talks about seeking medical attention after animal interactions as well as clinical treatment when people have been bit or scratched.
|Videos|September 21, 2016
The Evolution of Zika
Author(s)Contagion Editorial Staff
Pedro Fernando da Costa Vasconcelos, MD, PhD, director of WHO Collaborating Center for Arbovirus and Research, Evandro Chagas Institute, explains how Zika has evolved since the 1960s.
Advertisement
Pedro Fernando da Costa Vasconcelos, MD, PhD, director of WHO Collaborating Center for Arbovirus and Research, Evandro Chagas Institute, explains how Zika has evolved since the 1960s.
Interview Transcript (slightly modified for readability)
“[The] Zika virus [strains] that have been isolated and are circulating presently in the Americas are the same that were reported [to be] circulating in different Asian and Pacific Islands before they arrived here in the Americas. The evolution of these strains began in the 1960s, when the virus [spread] from Africa to Asia and generated a new genotype, the Asian genotype. This Asian genotype is the genotype that is currently circulating in Latin America [and North America].
This genotype is a little bit different from the African genotype, and the present lineage that is [circulating] in Latin America has very few differences from the virus [that was circulating in] the 1960s. The evolution of this virus was normal; the consequence [is that it hasn’t] changed too much, compared with the ancestral virus [strain].”
Advertisement
Related to this article
Jason Pogue, PharmD, BCPS, BCIDP, contextualizes preliminary data looking at this trial and other extended-spectrum beta-lactamase (ESBL) studies, which reopens the debate around carbapenem-sparing treatment options.
Following World Rabies Day and a CDC health advisory on a 17% rise in exposure-related calls, Rodney E. Rohde, PhD, explains what the increase means, what people should do when they have an animal bite or scratch, and how clinicians should assess risk and administer post-exposure prophylaxis (PEP).
Investigators accessed longitudinal human data from ebola virus vaccination for signals of efficacy against the Bundibugyo species now surging in the Democratic Republic of Congo.
In the first episode of our new series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
In mid-May, as the world was still grappling with an unexpected hantavirus outbreak aboard a tourism vessel, news broke of an Ebola outbreak in the Ituri Province of the Democratic Republic of the Congo spanning at least 3 health zones, including Bunia, Rwampara, and Mongbwalu.
A "Clinician Outreach" from the Centers for Disease Control and Prevention (CDC) in April anticipated an increase in rabies exposures, and the striking surge in case reports this summer prompted a recent health advisory alert from the federal agency.
Food expert Lynette Johnston, PhD, provides some context around the ongoing outbreak, discusses prevention, and compares 2026 food recalls with previous years.
Advertisement
Advertisement
Trending on Contagion Live
1
New IDSA/ESCMID S aureus Bacteremia Consensus Statements: a Risk Stratification Framework
2
On World Rabies Day, When to Seek Treatment, Clinical Considerations for Post Exposure Prophylaxis
3
Further Insights, Treatment Considerations Around the PETERPEN Study
4
VYD2311 Shows Superior Tolerability to mRNA COVID-19 Vaccine in Phase 3 Study
5